Anti-vascular endothelial growth factor for neovascular age-related macular degeneration-Reference-Cited by-同舟云学术

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration

Published:2014-08-29 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Solomon Sharon D¹,Lindsley Kristina²,Vedula Satyanarayana S³,Krzystolik Magdalena G⁴,Hawkins Barbara S¹

Affiliation:

1. Johns Hopkins University School of Medicine; Wilmer Eye Institute; 600 North Wolfe Street Maumenee 740 Baltimore Maryland USA 21287

2. Johns Hopkins Bloomberg School of Public Health; Department of Epidemiology; 615 North Wolfe Street, Mail Room E6132 Baltimore Maryland USA 21205

3. Johns Hopkins University; 3400 N. Charles Street Baltimore Maryland USA 21218

4. Southern New England Retina Associates; 1 Randall Square, Suite 206 Providence Rhode Island USA 02703

Publisher

Wiley

Subject

Pharmacology (medical)

Reference255 articles.

1. Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degeneration;Keane;Investigative Ophthalmology and Visual Science,2012

2. Contrast sensitivity outcomes in the ABC Trial: a randomized trial of bevacizumab for neovascular age-related macular degeneration;Patel;Investigative Ophthalmology and Visual Science,2011

3. The ABC trial - a randomized double-masked phase III study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularization secondary to age-related macular degeneration (AMD);Patel;Investigative Ophthalmology and Visual Science,2007

4. A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design;Patel;Trials,2008

5. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study;Tufail;BMJ,2010

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of Blepharoptosis Following Intravitreal Anti–Vascular Endothelial Growth Factor Injections;American Journal of Ophthalmology;2024-09

2. Factors Affecting Disease Stability After Intravitreal Brolucizumab Injection for Refractory Neovascular Age-Related Macular Degeneration;Ophthalmology and Therapy;2024-08-12

3. Enzyme-Responsive DNA Origami-Antibody Conjugates for Targeted and Combined Therapy of Choroidal Neovascularization;ACS Nano;2024-08-08

4. Evaluation of Anxiety Levels in Patients Undergoing Intravitreal Injection for Diabetic Macular Edema;Cukurova Anestezi ve Cerrahi Bilimler Dergisi;2024-06-30

5. Enhanced Ocular Delivery of Beva via Ultra‐Small Polymeric Micelles for Noninvasive Anti‐VEGF Therapy;Advanced Materials;2024-06-10